Oncolytics Biotech Inc
Oncolytics Biotech Inc., based in Calgary, Alberta, is committed to enhancing the lives of cancer patients through innovative therapies. Their lead product, pelareorep, is a unique immunotherapy designed to activate the immune system against various cancer types by selectively targeting cancer cells and bolstering immune response.
The company focuses on developing pelareorep for use alongside standard cancer treatments, aiming to improve outcomes for patients with conditions such as pancreatic and breast cancers. Oncolytics collaborates with key opinion leaders and regulatory bodies to optimize the development of this promising treatment, supported by encouraging data from various clinical trials.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.